- Home
- FHTX vs LESL Comparison
FHTX vs LESL Comparison
Compare FHTX & LESL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FHTX
- LESL
- Stock Information
- Founded
- FHTX 2015
- LESL 1963
- Country
- FHTX United States
- LESL United States
- Employees
- FHTX N/A
- LESL N/A
- Industry
- FHTX Medicinal Chemicals and Botanical Products
- LESL Diversified Commercial Services
- Sector
- FHTX Health Care
- LESL Miscellaneous
- Exchange
- FHTX Nasdaq
- LESL Nasdaq
- Market Cap
- FHTX 513.7M
- LESL 538.1M
- IPO Year
- FHTX 2020
- LESL 2020
- Fundamental
- Price
- FHTX $7.72
- LESL $2.83
- Analyst Decision
- FHTX Strong Buy
- LESL Hold
- Analyst Count
- FHTX 5
- LESL 9
- Target Price
- FHTX $16.00
- LESL $4.38
- AVG Volume (30 Days)
- FHTX 131.6K
- LESL 4.0M
- Earning Date
- FHTX 11-04-2024
- LESL 11-25-2024
- Dividend Yield
- FHTX N/A
- LESL N/A
- EPS Growth
- FHTX N/A
- LESL N/A
- EPS
- FHTX N/A
- LESL 0.02
- Revenue
- FHTX $25,515,000.00
- LESL $1,364,632,000.00
- Revenue This Year
- FHTX N/A
- LESL N/A
- Revenue Next Year
- FHTX $8.77
- LESL $3.67
- P/E Ratio
- FHTX N/A
- LESL $170.78
- Revenue Growth
- FHTX N/A
- LESL N/A
- 52 Week Low
- FHTX $2.70
- LESL $2.42
- 52 Week High
- FHTX $10.25
- LESL $8.21
- Technical
- Relative Strength Index (RSI)
- FHTX 42.02
- LESL 45.45
- Support Level
- FHTX $7.33
- LESL $2.70
- Resistance Level
- FHTX $9.33
- LESL $3.10
- Average True Range (ATR)
- FHTX 0.72
- LESL 0.20
- MACD
- FHTX -0.13
- LESL -0.02
- Stochastic Oscillator
- FHTX 16.46
- LESL 10.19
About FHTX Foghorn Therapeutics Inc.
Foghorn Therapeutics Inc is engaged in the discovery and development of a new class of medicines targeting genetically determined dependencies within the chromatin regulatory system. Its proprietary Gene Traffic Control platform gives an integrated, mechanistic understanding of how the various components of the chromatin regulatory system interact, allowing it to identify, validate, and potentially drug targets within the system. The company is developing FHD-286, a selective, allosteric ATPase inhibitor, and FHD-609, a protein degrader, to treat hematologic cancers and solid tumors.
About LESL Leslie's Inc.
Leslies Inc is a direct-to-consumer pool and spa care brand offering a comprehensive assortment of products across chemicals, equipment and parts, cleaning and maintenance equipment, and safety, recreational, and fitness-related products. The company offers its products and services for Residential Pool, Residential Spa, Professional Pool, and Commercial Pool consumers. Geographically, it operates only in the United States.